[1] Sacotte R, Silverberg JI.Epidemiology of adult atopic dermatitis[J]. Clin Dermatol, 2018,36(5): 595-605.
[2] Salimi M, Barlow JL, Saunders SP, et al.A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis[J]. J Exp Med, 2013, 210(13): 2939-2950.
[3] 梁晓冬,谈桂其,李春红,等. IL-33对特应性皮炎患者ST2-ILC2s轴及皮肤屏障影响的研究进展[J]. 皮肤性病诊疗学杂志,2021,28:237-240.
[4] Ryu WI, Lee H, Kim JH, et al.IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes[J]. Exp Dermatol, 2015, 24(11): 857-863.
[5] 唐羚洁,王佳曼,梁燕华. IL-33在特应性皮炎发病机制中的作用[J]. 皮肤性病诊疗学杂志,2018,25:116-119.
[6] Li M, Messaddeq N, Teletin M, et al.Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin[J]. Proc Natl Acad Sci U S A, 2005,102(41): 14795-14800.
[7] Gao PS, Rafaels NM, Mu D, et al.Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum[J]. J Allergy Clin Immunol, 2010, 125(6): 1403-1407.
[8] Wong CK, Hu S, Cheung PF, et al.Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation[J]. Am J Respir Cell Mol Biol, 2010, 43(3): 305-315.
[9] Imai Y.Interleukin-33 in atopic dermatitis[J]. J Dermatol Sci, 2019, 96(11): 2-7.
[10] 郑峥妮,刘文英,冯树晶,等. IgE高亲和力受体在树突状细胞和单核细胞的表达和意义[J]. 中华临床免疫和变态反应杂志,2021,15(2):194-200.
[11] Hvid M, Vestergaard C, Kemp K, et al.IL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?[J]. J Invest Dermatol, 2011, 131(1): 150-157.
[12] Fort MM, Cheung J, Yen D, et al.IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo[J]. Immunity, 2001, 15(6): 985-995.
[13] Kim BS, Siracusa MC, Saenz SA, et al.TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation[J]. Sci Transl Med, 2013, 5(170): 116r-170r.
[14] Doherty TA, Khorram N, Lund S, et al.Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production[J]. J Allergy Clin Immunol, 2013, 132(1): 205-213.
[15] Xue L, Salimi M, Panse I, et al.Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells[J]. J Allergy Clin Immunol , 2014, 133(4): 1184-1194.
[16] Roediger B, Kyle R, Yip KH, et al.Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells[J]. Nat Immunol, 2013, 14(6): 564-573.
[17] Boberg E, Johansson K, Malmhall C, et al.Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia[J]. Front Immunol, 2020, 11: 1058.
[18] Cox HE, Moffatt MF, Faux JA, et al.Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor[J]. J Am Acad Dermatol, 1998, 138(1): 182-187.
[19] Lou H, Lu J, Choi EB, et al.Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway[J]. J Immunol, 2017,198(7): 2543-2555.
[20] Wong C, Chu I, Hon K, et al.Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis[J]. Molecules, 2016, 21(4): 471.
[21] Kiehl P, Falkenberg K, Vogelbruch M, et al.Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining[J]. Br J Dermatol, 2015, 145(5): 720-729.
[22] Spergel JM, Mizoguchi E, Oettgen H, et al.Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis[J]. J Clin Invest, 1999, 103(8): 1103-1111.
[23] Kang EG, Narayana PK, Pouliquen IJ, et al.Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis[J]. Allergy, 2020, 75(4): 950-953.
[24] Chan LS, Robinson N, Xu L.Expression of Interleukin-4 in the Epidermis of Transgenic Mice Results in a Pruritic Inflammatory Skin Disease: An Experimental Animal Model to Study Atopic Dermatitis- ScienceDirect[J]. J Invest Dermatol, 2001, 117(4): 977-983.
[25] Kim BE, Leung DY, Boguniewicz M, et al.Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6[J]. Clin Immunol, 2008, 126(3): 332-337.
[26] Bogiatzi SI, Fernandez I, Bichet J, et al.Cutting Edge: Proinflammatory and Th2 Cytokines Synergize to Induce Thymic Stromal Lymphopoietin Production by Human Skin Keratinocytes[J]. J Immunol, 2007, 178(6): 3373-3377.
[27] Bao L, Shi VY, Chan LS.IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: Relevant in the pathogenesis of atopic dermatitis[J]. Cytokine, 2013, 61(2): 419-425.
[28] Oh MH, Oh SY, Yu J, et al.IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin[J]. J Immunol, 2011, 186(12): 7232-7242.
[29] Oetjen LK, Mack MR, Feng J, et al.Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch[J]. Cell, 2017, 171(1): 217-228.
[30] Grimstad Ø, Sawanobori Y, Vestergaard C, et al.Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis[J]. Exp Dermatol, 2009, 18(1): 35-43.
[31] Meng J, Moriyama M, Feld M, et al.New mechanism underlying IL-31-induced atopic dermatitis[J]. J Allergy Clin Immunol, 2018, 141(5): 1677-1689.
[32] Sakata D, Uruno T, Matsubara K, et al.Selective role of neurokinin B in IL-31-induced itch response in mice[J]. J Allergy Clin Immunol, 2019, 144: 1130-1133.
[33] Milovanovic M, Drozdenko G, Weise C, et al.Interleukin-17A Promotes IgE Production in Human B Cells[J]. J Invest Dermatol, 2010, 130(11): 2621-2628.
[34] Albanesi C, Scarponi C, Cavani A, et al.Interleukin-17 is Produced by Both Th1 and Th2 Lymphocytes, and Modulates Interferon-γ-and Interleukin-4-Induced Activation of Human Keratinocytes- ScienceDirect[J]. J Invest Dermatol, 2000, 115(1): 81-87.
[35] Sugaya M.The Role of Th17-Related Cytokines in Atopic Dermatitis[J]. Int J Mol Sci, 2020, 21(4): 1314.
[36] Leonardi S, Cuppari C, Manti S, et al.Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype[J]. Allergy Asthma Proc, 2015, 36(1): 74-81.
[37] Boniface K, Bernard FX, Garcia M, et al.IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes[J]. J Immunol, 2005, 174(6): 3695-3702.
[38] Gittler JK, Shemer A, Suárez-Fariñas M, et al.Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis[J]. J Allergy Clin Immunol, 2012, 130(6): 1344-1354.
[39] Tintle S, Shemer A, Suarez-Farinas M, et al.Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response[J]. J Allergy Clin Immunol, 2011, 128(3): 583-593.
[40] Lou H, Lu J, Choi EB, et al.Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway[J]. J Immunol, 2017, 198(7): 2543-2555. |
